Materna Care S.R.L.

The medical center is at the forefront of endometriosis research, focusing on innovative treatments to alleviate the condition's impact on women's health. The ongoing study evaluates the efficacy of AMY109, both alone and in combination with desogestrel, compared to desogestrel alone. This research aims to improve disease severity assessment through advanced techniques such as laparoscopic appearance and magnetic resonance imaging (MRI).

• Innovative treatment approaches
• Advanced diagnostic techniques
• Combination therapy evaluation

By exploring these novel therapeutic strategies, the center contributes significantly to enhancing the quality of life for women affected by endometriosis.

Specializing in the management of uncontrolled and resistant hypertension, the center conducts extensive research on lorundrostat, a promising antihypertensive agent. The study focuses on assessing the long-term safety, efficacy, and tolerability of lorundrostat, with particular attention to its impact on blood pressure and albuminuria. The research includes a double-blind, randomized treatment withdrawal substudy to evaluate the drug's effectiveness in maintaining antihypertensive effects.

• Long-term safety and efficacy studies
• Blood pressure improvement strategies
• Albuminuria reduction

This research is pivotal in developing new therapeutic options for patients with challenging hypertension cases, aiming to improve patient outcomes and overall cardiovascular health.